Search results: Sage Journals

Restricted accessResearch articleFirst published January, 1995

Clinical and Ethical Perspectives on Rationing of High-Cost Drugs

Therese I. Poirier, Vincent J. Giannetti

Annals of Pharmacotherapy

Open accessResearch articleFirst published November, 2016

Improving the Management of High Cost Anticancer Drugs in a Health Care System

Alberto Russi, Vera Damuzzo, Marta Serena [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Free accessResearch articleFirst published February, 2024

High-cost drugs for rare diseases: their expenditure and value based on a regional area-based study

Silvia Manea, Laura Visonà Dalla Pozza, Cinzia Minichiello [...]

Health Services Management Research

Available accessEditorialFirst published March, 2017

The misrepresentation of high drug costs

John A. Bachynsky, Ross T. Tsuyuki

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Restricted accessResearch articleFirst published August, 2014

Characteristics of judicialization of health in relation to drugs

Salamano Mercedes, Bianchi Mariela, Galati Elvio

Pharmaceuticals Policy and Law

Available accessOtherFirst published March, 2007

Manitoba Drug Plan Brings in New Option for Patients Facing High Drug Costs

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Restricted accessOtherFirst published April, 1998

Introduction: Off-Label Uses and High-Cost Drugs: Promotion and Reimbursement Issues

Sheila R. Shulman, Peg Hewitt

Therapeutic Innovation & Regulatory Science

Available accessReview articleFirst published 2026

Zopapogene Imadenovec-Drba for Recurrent Respiratory Papillomatosis

Christine M. Cheng

Annals of Pharmacotherapy

Available accessResearch articleFirst published August, 2017

Safety of Cancer Therapies: At What Cost?

Karen Fitzner, Frederick Oteng-Mensah, Patrick Donley [...]

Population Health Management

Restricted accessResearch articleFirst published December, 1991

What Price Prohibition? An Estimate of the Costs of Australian Drug Policy

Robert E. Marks

Australian Journal of Management

Restricted accessResearch articleFirst published January, 1995

Clinical and Ethical Perspectives on Rationing of High-Cost Drugs

Therese I. Poirier, Vincent J. Giannetti

Annals of Pharmacotherapy

Open accessResearch articleFirst published November, 2016

Improving the Management of High Cost Anticancer Drugs in a Health Care System

Alberto Russi, Vera Damuzzo, Marta Serena [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Free accessResearch articleFirst published February, 2024

High-cost drugs for rare diseases: their expenditure and value based on a regional area-based study

Silvia Manea, Laura Visonà Dalla Pozza, Cinzia Minichiello [...]

Health Services Management Research

Available accessEditorialFirst published March, 2017

The misrepresentation of high drug costs

John A. Bachynsky, Ross T. Tsuyuki

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Restricted accessResearch articleFirst published August, 2014

Characteristics of judicialization of health in relation to drugs

Salamano Mercedes, Bianchi Mariela, Galati Elvio

Pharmaceuticals Policy and Law

Available accessOtherFirst published March, 2007

Manitoba Drug Plan Brings in New Option for Patients Facing High Drug Costs

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Restricted accessOtherFirst published April, 1998

Introduction: Off-Label Uses and High-Cost Drugs: Promotion and Reimbursement Issues

Sheila R. Shulman, Peg Hewitt

Therapeutic Innovation & Regulatory Science

Available accessReview articleFirst published 2026

Zopapogene Imadenovec-Drba for Recurrent Respiratory Papillomatosis

Christine M. Cheng

Annals of Pharmacotherapy

Available accessResearch articleFirst published August, 2017

Safety of Cancer Therapies: At What Cost?

Karen Fitzner, Frederick Oteng-Mensah, Patrick Donley [...]

Population Health Management

Restricted accessResearch articleFirst published December, 1991

What Price Prohibition? An Estimate of the Costs of Australian Drug Policy

Robert E. Marks

Australian Journal of Management